Patent · US Active

CDK2 inhibitors

US11014911B2 · kind B2 · utility

2Cited by
5References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 28, 2020
Grant dateMay 25, 2021
Priority date—
Expiry dateJan 28, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/07
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to compounds of Formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.